You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ED-SCLC

Showing 1 - 25 of 2,290
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

Recruiting
  • Small Cell Lung Cancer
  • Lung Cancer
  • Aarau, Switzerland
  • +13 more
Aug 12, 2022

Small Cell Lung Cancer Extensive Stage Trial (Sintilimab, Anlotinib HCl)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • (no location specified)
Jul 26, 2021

Small Cell Lung Cancer (SCLC) Trial in France, Italy, United Kingdom (Pembrolizumab, cis/carboplatin and etoposide)

Active, not recruiting
  • Small Cell Lung Cancer (SCLC)
  • Avignon, France
  • +18 more
May 9, 2022

Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Completed
  • Lung Cancer
    • Barcelona, Spain
    • +1 more
    Jan 11, 2022

    Extensive-stage Small Cell Lung Cancer Trial in China (ZL-2306(nirapairb), Placebo)

    Terminated
    • Extensive-stage Small Cell Lung Cancer
    • Hefei, Anhui, China
    • +32 more
    Dec 16, 2020

    Lung Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Placebo)

    Completed
    Has Results
    • Lung Cancer
    • Nivolumab
    • +2 more
    • Sacramento, California
    • +195 more
    Jan 25, 2022

    EvaluatioN of durvALumab Utilization and Effectiveness for First

    Recruiting
    • Small Cell Lung Carcinoma
    • Angers, France
    • +24 more
    Jan 12, 2023

    Small Cell Lung Carcinoma Trial in Worldwide (coformulation pembrolizumab/quavonlimab, lenvatinib, MK-4830)

    Active, not recruiting
    • Small Cell Lung Carcinoma
    • coformulation pembrolizumab/quavonlimab
    • +3 more
    • Gilbert, Arizona
    • +46 more
    Jan 2, 2023

    Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

    Recruiting
    • Metastatic Non-small Cell Lung Cancer (NSCLC)
    • +5 more
    • data collection
    • Oldenburg, Germany
      Pius-Hospital
    Jul 20, 2022

    Small Cell Lung Cancer Trial in Worldwide (M3814, Cisplatin, Etoposide)

    Terminated
    • Small Cell Lung Cancer
    • Mesa, Arizona
    • +79 more
    Sep 11, 2020

    SCLC Trial in Shanghai (Carboplatin, Cisplatin, Etoposide)

    Active, not recruiting
    • SCLC
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 18, 2022

    SCLC, Brain Metastases Trial in Heidelberg (SRS, WBRT)

    Recruiting
    • SCLC
    • Brain Metastases
    • SRS
    • WBRT
    • Heidelberg, Germany
      University Hospital of Heidelberg, Department of Radiation Oncol
    Sep 28, 2021

    Small Cell Lung Carcinoma Trial in Goyang-si (IP chemo, IP chemo plus simvastatin)

    Active, not recruiting
    • Small Cell Lung Carcinoma
    • IP chemotherapy
    • IP chemotherapy plus simvastatin
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      National Cancer Center , Korea
    Apr 4, 2022

    Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

    Recruiting
    • Non-small Cell Lung Cancer
    • Extensive Disease Small Cell Lung Cancer
      • Akashi, Japan
      • +147 more
      Jun 23, 2021

      Small Cell Lung Cancer Trial in Italy (Etoposide, Carboplatin, Bevacizumab)

      Active, not recruiting
      • Small Cell Lung Cancer
      • Bologna, Italy
      • +14 more
      Sep 7, 2022

      Limited Stage Small Cell Lung Cancer, Extensive-stage Small-cell Lung Cancer Trial in Worldwide (Prophylactic cranial

      Not yet recruiting
      • Limited Stage Small Cell Lung Cancer
      • Extensive-stage Small-cell Lung Cancer
      • Prophylactic cranial irradiation
      • Graz, Austria
      • +37 more
      Jun 8, 2022

      Small Cell Lung Carcinoma Trial in Beijing (Tislelizumab, Anlotinib HCl)

      Recruiting
      • Small Cell Lung Carcinoma
      • Beijing, Beijing, China
        National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
      Nov 6, 2020

      Small Cell Lung Carcinoma Trial in Worldwide (Ipilimumab, Placebo matching Ipilimumab, Etoposide)

      Completed
      Has Results
      • Small Cell Lung Carcinoma
      • Ipilimumab
      • +4 more
      • Hot Springs, Arkansas
      • +224 more
      Jul 6, 2020

      Lung Cancer, NSCLC Stage IV, NSCLC, Stage III Trial in Linz, Innsbruck, Salzburg

      Recruiting
      • Lung Cancer
      • +4 more
        • Linz, Oberösterreich, Austria
        • +2 more
        Dec 3, 2020

        SCLC,Extensive Stage, SLFN11-positive Trial in Worldwide (Niraparib)

        Not yet recruiting
        • SCLC,Extensive Stage
        • SLFN11-positive
        • Angers, France
        • +19 more
        Jan 30, 2023

        Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

        Recruiting
        • SCLC,Extensive Stage
        • PD-(L)1 antibody immunotherapy
        • Beijing, Beijing, China
          Peking University Cancer Hospital & Institute
        Jul 3, 2023

        Small Cell Lung Cancer Trial in Worldwide (RO7051790)

        Completed
        • Small Cell Lung Cancer
        • Birmingham, Alabama
        • +7 more
        Oct 18, 2018

        Molecular Analysis and Treatment Options of SCLC

        Recruiting
        • Small-cell Lung Cancer
        • +4 more
        • Shanghai, China
          Shanghai Chest Hospital
        Jul 6, 2023

        Small-cell Lung Cancer Trial in Worldwide (Lurbinectedin (PM01183), Doxorubicin (DOX), Cyclophosphamide (CTX))

        Completed
        Has Results
        • Small-cell Lung Cancer
        • Lurbinectedin (PM01183)
        • +4 more
        • Birmingham, Alabama
        • +159 more
        Sep 29, 2021

        Outcomes ofBrazilian Cohort of Previously Untreated Extensive

        Not yet recruiting
        • Extensive-stage Small-cell Lung Cancer
        • Observational study
        • (no location specified)
        Aug 24, 2023